Table 3:
Duration of disease in patients with Graves’ disease, type 2 deiodinase gene Thr92Ala polymorphism genotypes.
D2 gene genotypes
T/T (
)
A/T (
)
A/A (
)
Total duration of the disease (months)
32.2 (7.9; 131.8)
16.8 (4.2; 67.1)
14.0 (5.6; 35.2)
0.007
Duration of overt thyrotoxicosis (months)
15.5 (5.9; 40.6)
10.9 (4.8; 25.0)
10.0 (4.2; 24.1)
0.04